4
Changes in Ownership
International Stem Cell CORP Filed Acc 0001019687-16-006375
Options or other derivatives
- Chief Executive Officer acquired 200,000 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
Semechkin Andrey · Chief Executive Officer
Table II: Derivative
1 line| Date | Transaction | Shares | Exercise | Expires | Underlying | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| 2016-05-17 | Grant or award : show line 1 in the form Stock Option (Right to Buy) | +200,000 | $2.30 | 2026-05-17 | 200,000 | 200,000 | D |
Loading xslF345X03/semechkin_f4.xml…